Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

17 HOURS AGO - Zacks Investment Research

A Must Read - Share

Amgen, Novartis Team Up; Bone Drug Positive in Phase III

Amgen (AMGN) inks deal with Novartis for Alzheimer's disease and migraine; reports positive phase III data on romosozumab.

Tags: Amgen, Novartis Team Up; Bone Drug Positive in Phase III,  Amgen Latest News

17 HOURS AGO - Wall Street Journal

A Must Read - Share

Novartis Closer to Selling Copy of Amgen's Neupogen

A federal appeals court in Washington denied Amgen Inc.’s request for a temporary injunction to block Novartis AG from selling a copycat version of the blockbuster drug Neupogen in the U.S.

Tags: Novartis Closer to Selling Copy of Amgen's Neupogen,  Amgen Latest News

17 HOURS AGO - Wall Street Journal

A Must Read - Share

Novartis Closer to Selling Copy of Amgen’s Neupogen

A federal appeals court in Washington denied Amgen Inc.’s request for a temporary injunction to block Novartis AG from selling a copycat version of the blockbuster drug Neupogen in the U.S.

Tags: Novartis Closer to Selling Copy of Amgen’s Neupogen,  Amgen Latest News

SEP 02, 2015 - Zacks Investment Research

A Must Read - Share

Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?

ARIAD's (ARIA) shares shot up on acquisition rumors; Amgen (AMGN) gained FDA approval for its potential blockbuster treatment, Repatha.

Tags: Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?,  Amgen Latest News

SEP 02, 2015 - TheStreet

A Must Read - Share

Sept. 2 Premarket Briefing: 10 Things You Should Know

NEW YORK (TheStreet) -- Here are 10 things you should know for Wednesday, Sept. 2: 1. -- U.S. stock futures were pointing to a rebound for Wall Street on Wednesday after the Dow Jones Industrial Average and S&P 500 posted their third-biggest daily declines of the year on Tuesday. European stocks fell again on Wednesday as a dip in euro-area industrial producer prices did ...

Tags: Sept. 2 Premarket Briefing: 10 Things You Should Know,  Amgen Latest News